Greg Madison, President and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 36,496 shares at $4.65 ($170K) on 2017-01-30, disclosed to the SEC on 2017-01-31.
Open-market sale of $170k KERX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.65 | 18,248 | $85K | 50.0% |
| 2 | $4.65 | 18,248 | $85K | 50.0% |
| Total | $4.65 avg | 36,496 | $170K | 100% |
| Filing → |
| KERX | SELL | 2017-10-31 | $24K | — | Filing → |
| KERX | SELL | 2017-10-06 | $6K | — | Filing → |
| KERX | SELL | 2017-08-01 | $29K | — | Filing → |